James R Cerhan, MD, PhD

Professor

  • 25453 Citations
  • 85 h-Index
1993 …2021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 11 Similar Profiles
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Confidence Intervals Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Odds Ratio Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Case-Control Studies Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1996 2021

Follicular Lymphoma
Molecular Epidemiology
Non-Hodgkin's Lymphoma
Genome-Wide Association Study
Single Nucleotide Polymorphism
Non-Hodgkin's Lymphoma
Lymphoma
Epidemiology
Cohort Studies
Outcome Assessment (Health Care)
Molecular Epidemiology
Non-Hodgkin's Lymphoma
Follicular Lymphoma
Lymphoma, Large B-Cell, Diffuse
Tumor Biomarkers
Slovakia
Case-Control Studies
Breast Neoplasms
Research
Interviews
Immunogenetics
Non-Hodgkin's Lymphoma
Survival
Cytokines
Chemokines

Research Output 1993 2019

Cause of death in follicular lymphoma in the first decade of the rituximab era: A pooled analysis of French and US cohorts

Sarkozy, C., Maurer, M. J., Link, B. K., Ghesquieres, H., Nicolas, E., Thompson, C. A., Traverse-Glehen, A., Feldman, A. L., Allmer, C., Slager, S. L., Ansell, S. M., Habermann, T. M., Bachy, E., Cerhan, J. R. & Salles, G., Jan 10 2019, In : Journal of Clinical Oncology. 37, 2, p. 144-152 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Cause of Death
Lymphoma
Disease-Free Survival
Rituximab

Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas

Ellin, F., Maurer, M. J., Srour, L., Farooq, U., Jerkeman, M., Connors, J. M., Smedby, K. E., Bennani, N. N., Ansell, S. M., Slack, G. W., Cerhan, J. R., Relander, T., Feldman, A. L. & Savage, K. J., Jan 1 2019, In : British journal of haematology.

Research output: Contribution to journalLetter

Open Access
Peripheral T-Cell Lymphoma

Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study

Wang, Y., Habermann, T. M., Wang, S. S., Maurer, M. J., Sarangi, V., Link, B. K., Feldman, A. L., Inwards, D. J., Witzig, T. E., Cozen, W., Rothman, N., Asmann, Y., Slager, S. L. & Cerhan, J. R., Jan 1 2019, In : American journal of hematology.

Research output: Contribution to journalLetter

Open Access
Mantle-Cell Lymphoma
Tumor Necrosis Factor-alpha
2 Citations (Scopus)

Incidence of AL Amyloidosis in Olmsted County, Minnesota, 1990 through 2015

Kyle, R. A., Larson, D. R., Kurtin, P. J., Kumar, S. K., Cerhan, J. R., Therneau, T. M., Rajkumar, S. V., Vachon, C. M. & Dispenzieri, A., Jan 1 2019, (Accepted/In press) In : Mayo Clinic Proceedings.

Research output: Contribution to journalArticle

Amyloidosis
Incidence
Immunoglobulin Light Chains
Congo Red
Medical Records
2 Citations (Scopus)

Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma

Hill, B. T., Nastoupil, L., Winter, A. M., Becnel, M. R., Cerhan, J. R., Habermann, T. M., Link, B. K., Maurer, M. J., Fakhri, B., Reddy, P., Smith, S. D., Mukhija, D., Jagadeesh, D., Desai, A., Alderuccio, J. P., Lossos, I. S., Mehra, P., Portell, C. A., Goldman, M. L., Calzada, O. & 9 othersCohen, J. B., Hussain, M. J., Ghosh, N., Caimi, P., Tiutan, T., Martin, P., Kodali, A., Evens, A. M. & Kahl, B. S., Feb 1 2019, In : British Journal of Haematology. 184, 4, p. 524-535 12 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Maintenance
Observation
Therapeutics
Vincristine